In the face of these urgent problems, many scholars found that SGK1 plays a significant role in the occurrence and development of Parkinson's disease, stroke, etc., suggesting that the regulation of SGK1 may be a therapeutic target or a potential drug. This evidence concerns the gene SGK1 and stroke disorder.